Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-03-16 4:15 pm Purchase | 13D | LIFECORE BIOMEDICAL INC LFCR | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 4,926,795 16.6% | 464,285 (+10.40%) | View |
2023-02-16 4:43 pm Purchase | 13G | S&W SEED CO SANW | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 4,112,950 9.7% | 4,112,950 (New Position) | View |
2022-12-02 4:15 pm Purchase | 13D | LIFECORE BIOMEDICAL INC LFCR | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 4,462,510 14.8% | 884,805 (+24.73%) | View |
2022-03-22 4:15 pm Sale | 13D | SUMMER INFANT INC SUMR | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 784,183 36.2% | -6,044,903 (-88.52%) | View |
2022-01-20 4:16 pm Purchase | 13D | LIFECORE BIOMEDICAL INC LFCR | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 3,577,705 12.1% | 387,400 (+12.14%) | View |
2021-04-20 4:15 pm Purchase | 13D | LIFECORE BIOMEDICAL INC LFCR | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 3,190,305 10.9% | 507,905 (+18.93%) | View |
2020-11-03 4:23 pm Purchase | 13D | MUSCLE PHARM CORP MSLP | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 2,111,874 6.4% | 100,000 (+4.97%) | View |
2020-10-28 3:57 pm Sale | 13D | MUSCLE PHARM CORP MSLP | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 2,011,874 6.1% | -31 (-0.00%) | View |
2020-08-14 5:14 pm Purchase | 13D | MVC CAPITAL, INC. MVC | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 1,559,270 8.8% | 44,891 (+2.96%) | View |
2020-07-13 2:07 pm Purchase | 13D | MUSCLE PHARM CORP MSLP | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 2,011,905 6.2% | 80,600 (+4.17%) | View |
2020-06-01 4:30 pm Unchanged | 13D | MVC CAPITAL, INC. MVC | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 1,514,379 8.5% | 0 (Unchanged) | View |
2020-04-27 4:47 pm Unchanged | 13D | MVC CAPITAL, INC. MVC | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 1,514,379 8.5% | 0 (Unchanged) | View |
2020-04-21 5:02 pm Unchanged | 13D | MVC CAPITAL, INC. MVC | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 1,514,379 8.5% | 0 (Unchanged) | View |
2020-01-22 4:19 pm Sale | 13D | MVC CAPITAL, INC. MVC | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 1,514,379 8.5% | -85,621 (-5.35%) | View |
2019-08-22 4:15 pm Purchase | 13D | MUSCLE PHARM CORP MSLP | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 1,931,305 12.6% | 47,792 (+2.54%) | View |